Dimethyl Fumarate as Potential Treatment for Alzheimer’s Disease: Rationale and Clinical Trial Design
![](https://sciaxis.org/wp-content/uploads/2023/06/old-patient-suffering-from-parkinson.jpg)
![](https://sciaxis.org/wp-content/uploads/2023/06/old-patient-suffering-from-parkinson.jpg)
Alzheimer’s Disease (AD) is a debilitating disease that leads to severe cognitive impairment and functional decline.NRF-2 has been identified in modulating the effects of inflammation and oxidative stress in AD. Activation of NRF-2 leads to an increased